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Background: High blood pressure is the principal risk factor for stroke, heart failure and kidney failure in the young
population in Africa. Control of hypertension is associated with a larger reduction in morbidity and mortality
in younger populations compared with the elderly; however, blood pressure control efforts in the young are
hampered by scarcity of data on prevalence and factors influencing awareness, treatment and control of hypertension.
We aimed to describe the prevalence of prehypertension and hypertension among young adults in a peri-urban
district of Uganda and the factors associated with occurrence of hypertension in this population.
Methods: This cross-sectional study was conducted between August, 2012 and May 2013 in Wakiso district, a
suburban district that that encircles Kampala, Uganda’s capital city. We collected data on socio-demographic
characteristics and hypertension status using a modified STEPs questionnaire from 3685 subjects aged 18–40 years
selected by multistage cluster sampling. Blood pressure and anthropometric measurements were performed using
standardized protocols. Fasting blood sugar and HIV status were determined using a venous blood sample. Association
between hypertension status and various biosocial factors was assessed using logistic regression.
Results: The overall prevalence of hypertension was 15 % (95 % CI 14.2 – 19.6) and 40 % were pre-hypertensive.
Among the 553 hypertensive participants, 76 (13.7 %) were aware of their diagnosis and all these participants had
initiated therapy with target blood pressure control attained in 20 % of treated subjects. Hypertension was significantly
associated with the older age-group, male sex and obesity. There was a significantly lower prevalence of hypertension
among participants with HIV OR 0.6 (95 % CI 0.4–0.8, P = 0.007).
Conclusion: There is a high prevalence of high blood pressure in this young periurban population of Uganda with
sub-optimal diagnosis and control. There is previously undocumented high rate of treatment, a unique finding that
may be exploited to drive efforts to control hypertension. Specific programs for early diagnosis and treatment of
hypertension among the young should be developed to improve control of hypertension. The relationship between
HIV infection and blood pressure requires further clarification by longitudinal studies.Background
Cardiovascular disease (CVD) is the leading cause of
death in developing countries contributing to 30 % of
all global deaths [1]. The age-specific mortality rates
from cardiovascular complications are much higher in
younger age groups for both sexes in Africa than in the
developed world [2, 3]. Hypertension is a driver of the* Correspondence: jkkayima@gmail.com
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bal deaths attributable to high blood pressure [4]. In
sub-Saharan Africa, high blood pressure is the leading
risk factor for heart failure, stroke and kidney failure,
which characteristically occur at younger ages [5–7].
The economic impact of hypertension in Africa is felt
directly by the individuals and the health care system
through the high costs incurred in treating complica-
tions; and indirectly through the loss of household in-
comes due to disability and death of these younger
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ment and control has been partly responsible for the
dramatic decline in morbidity and mortality in devel-
oped countries over the last thirty years [9, 10]. Blood
pressure levels from young adulthood predict the inci-
dence of future cardiovascular events and more signifi-
cant improvements in mortality and morbidity from
blood pressure control have been reported among youn-
ger subjects when compared to older ones [11, 12]. In
Africa, suboptimal blood pressure control remains chal-
lenging—a recent systematic review showed varied
prevalence and excessively low awareness, treatment and
control of hypertension [13]. There are limited data on
the prevalence of high blood pressure and its risk factors
among the young, whereas this is the population that
could derive the most benefit from control efforts. In
addition, the influence of novel risk factors for CVD
such as HIV infection has not been well described.
In Uganda, most of the available data on hypertension
has been hospital-based [14]. The few community stud-
ies that have been conducted pertain mainly elderly
population and have demonstrated an increasing burden
of hypertension and its risk factors associated with low
levels of awareness, low treatment coverage and poor
control [15–17]. The small sample sizes of generally older
adults from rural populations has limited generalizability
and hindered the formulation of a comprehensive policy
for prevention and control of hypertension among the
young. In this study, we investigated the prevalence and
factors associated with high blood pressure among youn-
ger adults in a peri-urban district of Uganda under the
Medical Education Partnership Initiative- Cardiovascular
Disease Survey (MEPI-CVD Survey).
Methods
Community survey
This cross-sectional study was conducted between August,
2012 and May 2013 among adults >18 years in Wakiso dis-
trict, Central Uganda. Wakiso district encircles Kampala,
the capital of Uganda, and is the most populous district in
the country with an estimated population of 2 million ac-
cording to the 2014 census [18]. This district is undergoing
rapid urbanisation due to its proximity with the capital city
yet it still has large areas of rural dwellings; a classic case of
the epidemiological transition. Wakiso has seven health
sub districts (HSD) each with a health center. In the hier-
archy of district health service organization the HSD is a
tier lower than the district.
Multi-stage sampling was used to select the HSD of
Wakiso district in which the survey was carried out.
First, the HSDs were stratified into rural and suburban
and then one sub-county was chosen from each
stratum by simple random sampling (Nansana town
council for the urban and Busukuma for the rural).Nansana has 23 villages, while Busukuma has 48 vil-
lages. All the households and other key features in
these villages were enumerated and mapped using
hand-held eTrex global positioning system (GPS) re-
ceivers (Garmin Ltd. Olathe, KS) to generate a sam-
pling frame. A household was defined as any single
permanent or semi-permanent dwelling acting as the
primary residence for a person or group of people that
generally cook and eat together. The mapping returned
26,757 periurban households and 13,091 rural house-
holds which were included in the randomization of
sample.
Prior to the survey day, mobilization teams of village
health team (VHT) members visited the study villages in
order to raise awareness of the study. The mobilization
of study villages focused on engaging with participants
at both a community and individual level, with the aim
of achieving and maintaining high levels participation.
This process involved meeting local leaders with letters
detailing the reason for the study and the duration of
planned work; holding a series of open community
meetings to increase general awareness of the study and
notifying study participants about the arrival of the study
team to ensure maximum participant availability.
A list of households to be approached for each site
was randomly computer generated from the enumer-
ation database. Study personnel visited the selected
households in sequential order to identify houses with at
least one adult resident to include in the study. Resi-
dents who were not home during the initial contact were
re-visited on three other occasions before excluding
them from the study. In each household, one adult
(>18 years old) was randomly selected to participate in
the survey. This person was briefed about the study in
the appropriate language and asked to attend a centrally
placed research clinic the following day after at least an
eight hour fast. Each participant was given a numbered
card for identification on the survey day. Households
were included if: 1) they had an adult aged 18 years or
older, and 2) the selected adult was willing to provide
written informed consent. Households were excluded if:
1) no adult resident was at home on more than 3 visits
or 2) if the household was vacant.
On the survey day, written consent from participants
in the study was sought and a survey instrument, based
on the World Health Organization (WHO) modified ex-
panded STEPs questionnaire [19] was administered by
research assistants. The survey instrument has three
levels. Level 1 contains the core or “minimum set” of
self-report measures including demographic data (age,
sex, and address), tobacco and alcohol consumption, ex-
ercise, smoke exposure, socio-economic status based on
housing characteristics, family history and personal
history of hypertension including the awareness of
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tory of treatment for these conditions if any. Level 2
contains simple physical measurements including height,
weight, waist circumference, and blood pressure. Level 3
assess biochemical measurements which involves col-
lecting venous blood collection for biochemical assess-
ments including fasting glucose and lipids. The survey
instrument was modified to gather information about
other non-traditional risk factors for cardiovascular dis-
ease such as HIV infection.
Blood pressure
Blood pressure and heart rate were measured with an
Omron automated sphygmomanometer model HEM-
907 whose accuracy has been validated [20]. Participants
were asked to refrain from smoking cigarettes and drink-
ing alcohol or caffeinated beverages for at least 30 min
prior to examination. The blood pressure in the left arm
was measured after resting for at least five minutes. The
blood pressure was taken in the sitting position, legs
uncrossed, with the arm resting on a table and the ante-
cubital fossa at the level of the lower sternum. Two arm
cuffs that fit arm circumferences 9–13 in. and 13–17 in.
were used in the process. Three blood pressure readings
were measured to the nearest mmHg three minutes
apart and the mean of the closest two values were used
for analyses [21]. Height was measured to the nearest
0.1 cm with a SECA 214 portable stadiometer while the
subjects stood barefoot on the centre of the base with
their back to the stadiometer. The weight was measured
to the nearest 0.1 kg with a SECA 762 scale. These re-
cordings were used to derive the body-mass index.
Laboratory measurements
Fasting venous blood samples were collected by stan-
dardized aseptic technique and were transported to a
laboratory for analysis within two hours of collection.
Glucose was measured immediately on site by a gluc-
ometer. Total cholesterol, high-density lipoprotein, and
triglyceride concentration were measured using Cobas
c111 automated chemistry analyzer (Roche Diagnostics
GmbH, Mannhein, Germany). The HIV status was deter-
mined using the rapid testing algorithm which included
the Determine HIV-1/2 assay (Abbott Laboratories,
Illinois, United States of America) for screening and the
HIV-1/2 STAT-PAK Dipstick assay (Chembio Diagnostic
Systems Inc., New York, USA) for confirmation of HIV
status.
Statistical analysis
Data were collected using hand-held computers pro-
grammed to include range checks, structure checks and
internal consistency checks. For this analysis we in-
cluded all participants between the ages of 18–40 years,stratified by younger (18–29) and older (30–40) groups.
The outcomes of interest were: (1) prehypertension de-
fined as systolic blood pressure between 120 and
139 mmHg and/or diastolic between 80 and 89 mmHg;
(2) hypertension which was defined as a systolic blood
pressure greater than 140 mmHg and/or a diastolic
blood pressure greater than 90 mmHg or treatment
with anti-hypertensive medication; (3) severity of
hypertension using categories defined by the United
States Seventh Joint National Committee on Detection,
Evaluation and Treatment of Hypertension (JNC-VII)
[22]; (4) awareness status defined as participants having
been told by a health worker that they had hyperten-
sion; (5) treatment status defined as any prescribed
treatment for high blood pressure including diet, exer-
cise, weight loss, smoking cessation and pharmaco-
logical therapy; and (6) blood pressure control defined
as treatment to a target systolic blood pressure of less
than 140 mmHg and diastolic less than 90 mmHg.
Categorical variables were summarized using frequency
(%), while continuous variables were summarized using
means. Univariable associations between hypertension
and potential risk factors were assessed using logistic
regression and all variables demonstrating an associ-
ation at a p < 0.2 significance level were candidates for
inclusion in the multivariable logistic regression model.
Logical model building using both forward and back-
ward elimination was used to generate a minimum ad-
equate model in a stepwise fashion using a p < 0.05
significance level for inclusion in the model. All statis-
tical analyses were carried out using Stata version 12.0
software (STATA Corporation, College Station, TX).
Ethical approval
The survey protocol was approved by the Makerere
University School of Medicine Research and Ethics
Committee and the Uganda National Council of Science
and Technology. Written informed consent was obtained
from all survey participants. Participants diagnosed with
clinical conditions including diabetes, hypertension, and
HIV infection were given initial treatment by our clinical
team and referred to the nearest health sub district center
for further follow up.
Results
A total of 3920 participants between the ages of 18 and
40 years were screened during the survey. Complete data
on hypertension and its determinants was obtained from
3685 (94 %) participants who were included in the ana-
lysis. Table 1 summarizes the characteristics of the study
participants. The majority of the participants (69 %)
were female. Seventy-eight percent were from the peri-
urban Nansana health sub-district. The median age of
the participants was 27 years; 62 % were in the young
Table 1 Socio-demographic characteristics of the study
participants aged 18–40 years in MEPI- CVD survey
Variable n (%)







Nansana Town Council (peri-urban) 2,866 (77.8)




Less poor 604 (16.4)
Least poor 965 (26.2)
Smoking
Never smoked 3,393 (92.1)
Previously smoked 117 (3.2)
Currently smoking 173 (4.7)
Alcohol
No intake 3,258 (88.5)
Mild intake 114 (3.1)
Moderate intake 219 (5.9)









Family history of high blood pressure (n, %)
No 2,775 (75.5)
Yes 903 (24.5)









Table 1 Socio-demographic characteristics of the study
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59 % of the study participants while 23 % were over-
weight and 12 % were obese. The HIV prevalence was
9.1 % of our study population compared to an estimated
nationwide prevalence of 7.3 % [23]. More baseline char-
acteristics are shown in Additional file 1: Table S1.Prevalence and distribution of hypertension and
prehypertension
The overall prevalence (95 % CI) of hypertension in this
population was 15 % (95 % CI 14.2 – 19.6 %) %. Figure 1
summarizes the prevalence of different stages of hyper-
tension among the study participants using JNC VII
classification according to both systolic and diastolic
blood pressure. Of all the study participants, 114 (3.1 %)
had severe hypertension (stage 2) and 402 (11 %) had
stage 1 hypertension. Only 45 % of participants had a
normal blood pressure and 41 % had prehypertension.
Figure 2 shows the stages of hypertension by age group.
The prevalence of prehypertension was similar in both
age groups; however, hypertension was more prevalent
in the older age group (10.8 % vs 21.6 %, p = 0.001).Factors associated with hypertension
In this survey population, female participants were less
likely to be hypertensive compared to men OR 0.7
(95 % CI 0.6–0.8, P < 0.001). See Additional file 2:
Table S2. There was a trend towards increased preva-
lence of hypertension among participants with higher
socioeconomic status which was not significant after
multivariable adjustment. There was also a non-
statistically significant trend towards increased hyperten-
sion prevalence among smokers and those with heavy
alcohol intake. The participants’ diabetes status (history
of diabetes and diagnosis of diabetes during the survey)
was positively associated with hypertensive status 3.1
(0.9–10.8, p = 0.007). Participants with HIV infection
were less likely to be hypertensive in this study popula-
tion OR 0.6 (95 % CI 0.4–0.8, p = 0.007). There was a
graded increase in hypertension prevalence among the
overweight and obese participants in the survey.
Fig. 1 Prevalence of different stages of hypertension among adults (age 18–40 years) in Wakiso district central Uganda. Error bars represent
standard deviation. HT: hypertension
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Figure 3 shows the proportions of awareness, treatment
and control among the hypertensive study participants.
Among the 553 hypertensive participants, 76 (13.7 %) were
aware of their condition and all were on some form of ther-
apy. Most of the participants on treatment (47.7 %) used
only pharmacological means for control of blood pressure,
while the minority used on the non-pharmacological means
including exercise, diet and smoking cessation. The
participants who used both pharmacological and non-
pharmacological means of treatment achieved better con-
trol of hypertension with more than a quarter of them
attaining target blood pressure. Only about 10 % of those
using pharmacological means only were treated to target.
Overall, control was achieved in a fifth of the population.
Figure 4 shows treatment, awareness and control of hyper-
tension among the study population by age-group. TheFig. 2 Hypertension classified using the JNC VII criteria by age-group amon
represent standard deviationawareness and treatment of hypertension (18 %) was higher
in the older age group compared to the younger group
(8.1 %); however, the younger age group had better control
of hypertension with 40 % of all treated hypertensive con-
trolled compared to 13 % in the older age-group.
Discussion
In order to develop a more coherent policy for the con-
trol of hypertension and for the mitigation of its adverse
outcomes in Uganda, it is important to have a more pre-
cise estimate of the prevalence of the condition and to
determine the factors that are associated with it. Our re-
sults demonstrate that high blood pressure is highly
prevalent in this young population with almost a sixth of
the study population being classified as hypertensive.
The prevalence of hypertension in our study population
is comparable to that of other young populations ing adults (age 18–40 years) in Wakiso district Central Uganda. Error bars
Fig. 3 Awareness, treatment and control of hypertension among
adults (age 18–40 years) in Wakiso district, central Uganda. HTN:
hypertension; Pharm: pharmacological means of treatment;
Non–pharm: non-pharmacological means of treatment
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in Ethiopia to 23 % in Tanzania [24, 25]. Comparison
with recent studies in Uganda was difficult as most of
them have considered elderly populations with few
young participants [15]. Other studies such as Wamala
et al. and Musinguzi et al. have focused mainly on rural
districts in Western and Central Uganda, respectively,
with only a few trading centres within the study sites
considered periurban [16, 17]. While these studies did
not intently focus on young subjects, the prevalence ofFig. 4 Prevalence, awareness and control by age-group among adults (age
standard deviationshypertension in their younger subjects at 16.7 % was
strikingly similar to that in our population. The young
subjects in this survey may be more representative of
the Ugandan adult population, which according to the
national census is fairly young with a median age of
15.5 years [18]. Equally important is the finding of high
prevalence of prehypertension in this survey considering
that there is good evidence that prehypertension in
young individuals significantly raises cardiovascular risk
[26–28]. The increasing prevalence of hypertension and
prehypertension in Africa has been blamed on accultur-
ation- the adoption of Western ways of living in places
with rapid urbanisation. Dietary trends toward higher
sodium and lower potassium are widespread throughout
rural and urban areas of Africa. Our study is a classic
example of a population undergoing epidemiological tran-
sition due to rapid urbanization. Because appropriate
management of the complications of hypertension may
not be attainable in some African settings due to limited
resources, primordial methods of prevention that stress
lifestyle changes ought to be directed towards young
adults to improve long-term outcomes.
Despite the high prevalence of hypertension, less
than a fifth of the subjects with hypertension were
aware of their condition. The finding of sub-optimal
diagnosis in our survey is consistent with observa-
tions in other developing countries outside Africa, but
also in the developed world where diagnosis of hyper-
tension in the young population is usually low [29].
In developed countries physician inertia and health
disparities have been blamed for the low levels of
diagnosis while in Africa weak health systems related to
both structure and financing are thought to contribute to18–40 years) in Wakiso district Central Uganda. Error bars represent
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hypertension should focus on identifying younger subjects
with or at-risk for hypertension especially because there is
evidence that prevention and treatment of hypertension in
young people is associated with greater risk reductions
than in the elderly [12]. In many randomised controlled
trials in the developed countries, community screening
has led to an improved detection of hypertension [31].
All participants who were aware of their hypertensive
status were on some form of treatment with control to
target achieved in only a fifth of those treated. A multi-
faceted approach to therapy using both antihypertensive
drugs and lifestyle measures delivered better control of
hypertension. The finding of high treatment rates is an
uncommon finding in this African setting with treatment
rates in other parts of Africa ranging from 5 % in a rural
Nigerian community to 91.2 % in urban North African
populations [13]. The exceptional levels of hypertension
treatment may be explained by improved public-health
messaging on the dangers of hypertension from the
Uganda Ministry of Health in Wakiso District, which is
often the first recipient of health promotion efforts [32].
The poor control of hypertension despite treatment is
comparable to that in many African countries and may
be related to health system related deficiencies which are
common in African settings [33, 34]. Because control to
target is the ultimate predictor of outcomes for hyperten-
sive patients, these findings call for a concerted effort to
improve these statistics in sub-Saharan Africa. The
utilization of both drugs and lifestyle modification to treat
hypertension is now recommended as an approach to de-
liver more sustainable control of blood pressure in young
individuals [35]. In addition, leveraging chronic disease
care models from the highly successful HIV/AIDS control
efforts has been proposed as a health system alternative
for non-communicable disease treatment and control.
Among other components, these models have included
task-shifting, health systems strengthening and support
for adherence and retention [36].
In our study, hypertension was more prevalent in the
older population, consistent with the known epidemiology
globally and in other parts of Africa [15, 16, 37]. While age
related increase in blood pressure is currently considered a
universal feature of human aging, the trajectory of this in-
crease has been shown in longitudinal studies to be steeper
among younger subjects in settings undergoing rapid
urbanization [38, 39]. Recent studies have revealed that this
age-related rise in blood pressure seems to occur much
later in subjects with better cardiorespiratory fitness stres-
sing the necessity of primary prevention of hypertension
[38]. In addition to age related differences in hypertension
prevalence, gender-related differences were prominent in
our study, with the men having a significantly higher
prevalence. Gender differences in hypertension have beenstudied extensively. It is well-recognized that young men
are more likely to develop high-blood pressure and have
poorly controlled hypertension than premenopausal
women, a dynamic that has been attributed to androgen
mediated abnormalities in pressure natriuresis [40, 41].
However, large meta-analyses of hypertension treatment
trials have failed to document gender differences in re-
sponse to antihypertensive medication meaning that the
poor control of hypertension documented in men is prob-
ably due to socio-economic and cultural factors [42]. This
finding calls for the formulation of gender specific pro-
grams to address the gender differences in access to and
utilization of health care facilities for the control of
hypertension.
The HIV infection prevalence in our study population
was higher than the national prevalence of 7.4 % [23].
These HIV infected participants were less likely to be
hypertensive than the uninfected participants. The results
of studies on effect of HIV on hypertension prevalence in
the Africa have been inconsistent. There have been sug-
gestions that antiretroviral therapy has not only increased
life expectancies for HIV-infected adults but has also put
them at greater risk for central obesity and hypertension
[43, 44]. However, most of these studies have been in HIV
infected cohorts with no comparable group. Recent stud-
ies in African settings that included HIV-uninfected com-
parison groups are in agreement with our findings of a
lower prevalence of hypertension in HIV infected individ-
uals, regardless of whether they were taking anti-retroviral
drugs or not [45–47]. Dysregulation of sympathetic ner-
vous system and hypoadrenalism have been suggested to
account for the lower blood pressures found in HIV
infected patients and may be associated with increased
mortality [48–50]. Because we lacked data on current
CD4+ T-cell count or HIV-1 viral load, our study was un-
able to explore covariates that may have been associated
with low or high blood pressure in the HIV-infected
population.
Over a third of our study population was overweight or
obese which were significantly associated with hyperten-
sion as expected. The positive relationship between body
weight and blood pressure has been reported in longitu-
dinal studies and has been replicated in other rapidly
urbanizing settings in sub-Saharan Africa [51, 52]. The
growing obesity epidemic in sub-Saharan Africa has been
largely attributed to increasing consumption of western-
style diets high in sugar and fat [53]. However, cultural
perceptions that value heavier body weight as a sign of
wellbeing and wealth cannot be underestimated [54, 55].
To be able to successfully confront obesity-related hyper-
tension in Africa, education on the consequences of obes-
ity should be an integral part of control efforts.
Some strengths of this survey warrant to be men-
tioned. To our knowledge this is the first study that has
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logical transition in East Africa. Our findings are poten-
tially generalizable to similar age groups in similar
rapidly urbanizing settings. Our survey had a relatively
large sample size, employed rigorous epidemiologic
methods including training of the research assistants
and standardized instruments and had high response
rate which contributed to strength of the study. Certain
limitations should be considered in the interpretation of
the study results. First, known history of hypertension
was self-reported and therefore prone to recall bias. This
could have led to overestimation of rates of awareness
and control of hypertension; however, prior studies have
validated self-report as a way of determining the diagnosis
of hypertension [56]. Secondly, blood pressure was mea-
sured at a single point in time because of the difficulty of
multiple measurements in a survey of this magnitude;
however, the method of blood pressure measurement was
highly standardized and performed in triplicate after an
adequate rest period. Finally, data on medication adher-
ence were not collected as a possible predictor of hyper-
tension control.
Conclusions
Overall, the findings of this survey reveal a high preva-
lence of elevated blood pressure (prehypertension and
hypertension) in this young periurban population with
suboptimal levels of diagnosis and control. We docu-
mented a high rate of treatment, a unique finding that
may be exploited to drive efforts to control hypertension.
Hypertension was significantly associated with the older
age group, male sex and being overweight or obese while
HIV infection was negatively associated with high blood
pressure. Specific programs for early diagnosis and treat-
ment of hypertension among the young should be devel-
oped to improve control of hypertension. The relationship
between hypertension and HIV infection needs further
clarification in longitudinal studies.
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